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a b s t r a c t
A 41-year-old female with history of Graves' disease, bilateral cataract, paroxysmal atrial
ﬁbrillation was admitted because of muscle weakness, daytime sleepiness, fatigability,
drowsiness, bilateral eyelid ptosis, descending of head and lower jaw. On neurological
examination the patient was presented with muscle weakness, muscle atrophy (in face
and sternocleidomastoid muscles), features of myotonia and apocamnosis (orbicular mus-
cles). Electromyography revealed myopathic changes, myotonic and pseudomyotonic dis-
charges, positive repetitive nerve stimulation test in proximal muscles. Myotonic dystrophy
(MD) diagnosis was conﬁrmed by genetic testing and myasthenia gravis (MG) by a positive
titer of cholinergic receptor autoantibodies. In the CSF concentration of hypocretin was
signiﬁcantly decreased.
© 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Myasthenia gravis (MG) and myotonic dystrophy (MD) lead to a
dysfunction of motor unit, although they both differ clinically
and pathogenetically. Coincidence of MG and MD in one
patient is extremely rare [1–6].
Hyperthyroidism may also lead to muscle dysfunction [7,8].
Though endocrine disorders like hypogonadism or glucose
intolerance are typical for MD patients, hyperthyroidism is
rarely reported in these subjects [7,8]. However in MG, Graves'* Corresponding author at: Department of Neurology, Medical Univers
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diagnosed more often than in general population [9].
To the best of our knowledge, coexistence of MD, MG and
Graves' disease in one patient has never been reported and it is
the ﬁrst case report describing such a patient.
2. Case report
A 41-year-old female farmer with one-year history of Graves'
disease was referred to the Department of Neurology with aity of Bialystok, ul. Sklodowskiej 24 A, 15-276 Bialystok, Poland.
a), rpog@mp.pl (R. Pogorzelski), amirtarasiuk@wp.pl (J. Tarasiuk),
erlangen.de (P. Lewczuk), alakul@umb.edu.pl (A. Kułakowska).
p. z o.o. All rights reserved.
Fig. 2 – Decrement seen on repetitive nerve stimulation test
in the patient's right deltoid muscle.
Fig. 1 – (a) Myotonic discharge seen in patent's right first
dorsal interosseous muscle. (b) Pseudomyotonic discharge
seen in patient's right anterior tibial muscle.
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decreasing of her head and a lower jaw, and reported also
muscle weakness, fatigability and drowsiness making walking
long distances impossible. The patient had a history of
bilateral cataract (already treated surgically in her both eyes)
and biliary calculosis. She complained of cardiac arrhythmia
(diagnosed as paroxysmal atrial ﬁbrillation) and frequent
respiratory tract infections. She had a history of respiratory
insufﬁciency in the postoperative period after appendectomy.
There had been cases of cataract and muscle weakness in the
patient's family that were reported by her but not extensively
diagnosed: her uncle and aunt had difﬁculties with walking.
They died in their middle age of an unknown reason, leaving
no descendants. Our patient's mother was operated on
bilateral cataract at the age of 50. She did not complain of
any muscle weakness and she died at the age of 76 because of a
neoplasm, which might have been a case of a mild type of MD
with a leading symptom of bilateral cataract, as it is known
that myotonia and muscle dystrophy are not always present in
that type of MD [10,11].
Our patient has three children and two of them (a 13-year-
old son and 21-year-old daughter) do not report any health
problems. Neurologic examination did not revealed any
abnormalities. Her 17-year-old son is moderately mentally
impaired with a signs of myotonia seen on neurological
examination. His EMG examination showed a presence of a
myopathic process and myotonic and pseudomyotonic dis-
charges in tibialis anterior and extensor digitorum muscles.
Decrement test from both proximal and distal muscles was
normal. We diagnosed him with a childhood type of MD, where
learning difﬁculties are the early sign followed by myotonia
and muscle atrophy [10,11].
On admittance, the patient was presented with generalized
muscle weakness, muscle atrophy – especially in her face and
sternocleidomastoid muscles and features of myotonia (difﬁ-
culty with grip release). There was apocamnosis seen in
orbicular muscles of her eyes, but it was difﬁcult to evaluate in
hand muscles. She was hyperthyreotic. Her twenty-four hour
glycaemic proﬁle, cortisol secretion and synacthen test were
normal.
Electromyography revealed myopathic changes (low-am-
plitude, short-duration, polyphasic motor unit potentials) with
signiﬁcant spontaneous activity consisting of both myotonic
and pseudomyotonic discharges (Fig. 1a and b). Repetitive
nerve stimulation was negative in distal hand muscles but
positive (resulting in signiﬁcant decrement in successively
evoked muscle action potentials) in proximal deltoid muscles
(Fig. 2). An edrophonium test was clinically and electrophysi-
ologically positive. Her mediastinum CT did not reveal any
changes coherent with a persistent thymus and/or a thy-
moma.
MD diagnosis was conﬁrmed by genetic testing performed
at Department of Human Genetics, University of Ulm,
Germany which revealed mean number of 735 (ranging from
535 to 935) CTG triplet copies in locus 13.2 of chromosome 19q.
MG diagnosis was conﬁrmed by a positive titer of ACh receptor
autoantibodies – 4.03 nmol/l (normal range – below 0.25 nmol/
l). Based on her medical history, neurological and electrophys-
iological examination the patient was diagnosed with Graves'
disease, MD and MG.Because of an excessive daytime sleepiness (15 points
Epworth scale [12]), CSF/serum analysis was done, showing
unaltered total protein concentration normal cell count as well
as albumin, IgG, IgA, and IgM CSF/serum concentration
quotients. Isoelectrofocusing revealed identical bands pattern,
conﬁrming lack of intrathecal IgG synthesis. Nevertheless,
decreased concentration of hypocretin concentration (80 pg/
ml; normal range >100 pg/ml) was found, which may be
connected with excessive daytime sleepiness present in our
patient.
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pyridostigmine (180 m daily). Pharmacological treatment of
hyperthyreosis with methimazole and propylthiouracil was
not effective and that is why the patient was treated with
radioactive iodine I 131 with good results. A treatment with
pyridostigmine and normalization of thyroid gland endocrine
function resulted in a partial improvement of patient's general
condition (an improvement of muscle strength, lesser muscle
weakness and better walking dexterity) with no change in
myotonic signs. An EMG examination carried out while the
patient was in euthyreosis showed changes typical for both
MG and MD.
The patient was monitored regularly by a neurologist and
an endocrinologist in our outpatient facility. Her general
medical state has not changed for the last year.
3. Discussion
It is estimated that a coincidence of MG and MD in one patient
is 1 per 700 million people [1]. We have found six case reports
describing a patient diagnosed with both MG and myotonic
disorders [1,6]. Schoen described a case of a 13-year-old girl
with MD, who developed symptoms of MG [1]. Matsumoto et al.
reported a case of a 32-year-old patient diagnosed with MG and
myotonia [2]. Two case reports described myotonic dystrophy
type 1 coexisting with myasthenia gravis and thymoma [4,5].
Several reports described a coincidence of MD and MG in one
family [3]. Based on present knowledge on MD and MG it seems
there is no signiﬁcant pathogenetic link between those two
diseases and their coincidence is probably incidental [3].
Apart from having both MD and MG, in the patient reported
Graves' disease was diagnosed. Hyperthyreosis potentiated
muscle weakness caused by MG and MD [8] and an
achievement of euthyreosis resulted in alleviating of thyr-
eotoxic myopathy symptoms. Muscle fatigability was de-
creased by introducing an acetylcholinesterase inhibitor.
Treatment with pyridostigmine did not intensify myotonia,
what was also noted by Schoen [1].
Hyperthyreosis is diagnosed in about 5% of myasthenic
patients [13]. Thyroid gland hormones are usually within
normal range in patients with MD, although endocrinological
disturbances are quite common in a course of MD. We have
found only several published reports describing coincidence of
hyperthyroidism and myotonic dystrophy [8].
Because of patient's excessive daytime sleepiness the CSF
examination was done showing decreased hypocretin. Mea-
surement of CSF hypocretin in patients with myotonic
dystrophy has shown a signiﬁcantly lower level in 6 patients
with myotonic dystrophy, suggesting a dysfunction of the
hypothalamic hypocretin system [14]. Therefore, Ciafaloni
et al. did not observe low hypocretin levels in any of 38 MD 1
diagnosed patients [15] and based on this study a hypothesis
about different pathogenetic background of a narcolepsy in
MD1 was proposed. In myotonic dystrophy, weakness and
myotonia of the upper airway and other respiratory muscles,
as well an inherited membrane abnormality involving the
respiratory and hypnogenic neurons in the brainstem, may be
responsible for excessive daytime sleepiness. Many patients
with myotonic dystrophy have been described with centraland upper airway obstructive sleep apneas, alveolar hypo-
ventilation and daytime fatigue [16,17].
We think that the patient reported here is an interesting
case showing that dysfunction of a neuromuscular system
might have complex pathophysiologic and genetic back-
ground. Although extremely rare, such a combination of
pathophysiologic pathways, as this reported here, might point
at some common mechanisms of these, currently treated as
completely distinct, neuromuscular disorders.
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